From Passion Project to Scalable Fragrance Brand
Ôrebella is Bella Hadid’s founder-led fragrance brand that illustrates how celebrity fragrance brands evolve from passion projects into scalable businesses by pairing star-driven storytelling with professional leadership and institutional capital. Launched in 2024 with a skin-friendly, bi-phase “skin parfum” concept, Ôrebella moved quickly from debut to distribution across Ulta Beauty in its home market. The brand then extended to Ulta Beauty Middle East, where it now holds the number one fragrance position, and secured listings in 500 Douglas stores across 20 markets, plus a presence at Selfridges. This rapid footprint shows strong early demand but also pressure on operations, supply chain and retail execution. To support what it calls “accelerated growth”, Ôrebella has now tied creative direction to a more formal business infrastructure, setting up a model that many emerging celebrity fragrance labels are likely to copy.
Why Ôrebella Brought In Beauty Veteran Anish Agarwal
The appointment of Anish Agarwal as CEO marks a clear shift from founder-led hustle to structured beauty brand leadership. Agarwal brings more than 20 years’ experience at Colgate-Palmolive and L’Oréal, followed by his role as CEO of luxury hair tools brand T3 Micro, where he is credited with reinvigorating the company and expanding in prestige retailers such as Ulta Beauty and Sephora. Hadid keeps control of creative and strategic direction, including scent development and brand storytelling, while Agarwal partners with general manager Alison Romash on execution. This split mirrors how maturing celebrity fragrance brands balance personality-led equity with operational discipline. Agarwal has said he aims to build a “distinctive brand, scaling strategically, strengthening execution, and bringing Ôrebella to more people around the world while staying true to what makes it so special,” underscoring his mandate to scale without diluting identity.
Series A Funding: Building the Infrastructure for Growth
Ôrebella’s Series A funding, led by beauty-focused investor Silas Capital with participation from incubator Celebrands, signals the brand’s move into the arena of institutional-backed scaling. While the amount is undisclosed, the mandate is clear: support product innovation, operational scaling and international retail growth. According to Silas Capital partner Brian Thorne, Ôrebella has “built a clear and differentiated position in fragrance, supported by strong early performance and a highly engaged consumer base.” For celebrity fragrance brands, this type of Series A funding beauty round does more than add cash; it brings governance, performance expectations and access to seasoned advisers. Growth equity firms typically push for tighter inventory management, more rigorous data around sell-through, and a defined roadmap into new geographies or adjacent categories. In Ôrebella’s case, investors also see potential to extend its bi-phase skin parfum technology into wider beauty segments over time.
Competing in a Crowded Celebrity Fragrance Landscape
The celebrity fragrance market is crowded, so Ôrebella’s challenge is scaling while standing out. Its edge lies in a clear product story—the bi-phase, skin-friendly parfum system—and strong early signals such as Jasmine Blues, its sixth fragrance, selling at twice its forecast in the US. With a full-chain launch at Ulta Beauty, top ranking in Ulta Beauty Middle East and a fast rollout across Douglas stores, the brand is already present where prestige fragrance shoppers browse. Series A funding beauty investors and seasoned executives like Agarwal help translate this momentum into durable market share. They can refine pricing architecture, manage retailer negotiations and plan inventory to support repeat purchases rather than one-time impulse buys. For celebrity fragrance brands broadly, Ôrebella provides a blueprint: pair a distinct concept with disciplined fragrance brand scaling, then use professional leadership to convert fan excitement into a lasting business.
